FACT CHECK #7CQ6AN1T

WHAT WE FOUND

While intermittent fasting and fasting-mimicking diets are currently being researched for their potential benefits in oncology, there is no scientific evidence or clinical data supporting the claim that a single seven-day fast reduces lifelong cancer risk by 70 percent. Studies have indicated that fasting may help protect healthy cells and sensitize cancer cells during chemotherapy1. Furthermore, long-term calorie restriction has been associated with reduced spontaneous tumor incidence in certain animal models1. Researchers at institutions like Cedars-Sinai are actively exploring fasting as a complementary therapy during conventional cancer treatment2. However, the specific assertion that a one-time fasting event confers a 70 percent lifelong risk reduction in humans is completely unsubstantiated by current medical literature. Because cancer risk is cumulative and influenced by genetics, environment, and long-term habits, no single short-term dietary intervention is scientifically recognized as providing such a permanent and drastic risk reduction.

SOURCES

1. 1 · vertexaisearch.cloud.google.comACADEMIC
   nih.gov

   TIER A

2. 2 · vertexaisearch.cloud.google.comWEB
   cedars-sinai.org

   TIER B